CJCP     2024 26 (5):  444-449    ISSN: 1008-8830  CN: 43-1301/R Safety considerations for the clinical application of recombinant human growth hormone PAN Hui, DU Hong-Wei Department of Pediatrics, First Bethune Hospital of Jilin University, Changchun 130021, China Received: 2023-10-13  Revised: null  Online: null Supporting info null